Skip to main content

Progenitor Cell Therapy for Neurological Injury

  • Book
  • © 2011

Overview

  • The text provides an up-to-date focused review on non-embryonic progenitor cell therapeutics for neurological injuries
  • Translational barriers to adoption of progenitor based cell therapeutics is a central theme of the text
  • This is a single source for a broad overview of the status of pre-clinical proof of concept data and early translational trials using progenitor cells for neurological injury
  • Includes supplementary material: sn.pub/extras

Part of the book series: Stem Cell Biology and Regenerative Medicine (STEMCELL)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (9 chapters)

Keywords

About this book

There are currently no reparative therapies for severe neurological injury, including brain injury, spinal cord injury and stroke. Actually, most treatments are designed simply to limit secondary damage. However, pre-clinical data supports the idea that exogenous stem and progenitor cells have the potential to promote a reparative response to severe neurological injuries. Progenitor Cell Therapy for Neurological Injury is a compilation of seminal essays that explore many unique aspects of neurological injury, focusing on the critical translational issues of cell delivery. Specifically, it discusses routes of administration, types of progenitor cells (alone and/or in combinations), timing of delivery and adjuncts to promote cell engraftment, survival and effectiveness. In addition, many chapters address measuring the effects of transplanted cells and cell tracking. The paradigms of how cell-based therapeutics affect neurological injury is changing rapidly. The developments in this field may ultimately offer realistic hope for improvement in patients with severe injuries. This book is a vital key toward unlocking those future treatments.

Reviews

From the reviews:

“This book is an example of the cumulative effort over the past few years. The purpose is to address the use of progenitor cells in the management of neurological diseases. … Neurologists, neurosurgeons, neurophysiologists, neuroscientists, and molecular biology and transplantation scientists are the intended audience. … The book is well written, referenced, and illustrated.” (Celso Agner, Doody’s Book Reviews, April, 2012)

Editors and Affiliations

  • Medical School at Houston, Div. Pediatric Surgery, University Texas, Houston, USA

    S. Charles

Bibliographic Information

  • Book Title: Progenitor Cell Therapy for Neurological Injury

  • Editors: S. Charles

  • Series Title: Stem Cell Biology and Regenerative Medicine

  • DOI: https://doi.org/10.1007/978-1-60761-965-9

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: Springer Science+Business Media, LLC 2011

  • Hardcover ISBN: 978-1-60761-964-2Published: 17 November 2010

  • Softcover ISBN: 978-1-61779-717-0Published: 27 December 2012

  • eBook ISBN: 978-1-60761-965-9Published: 25 November 2010

  • Series ISSN: 2196-8985

  • Series E-ISSN: 2196-8993

  • Edition Number: 1

  • Number of Pages: X, 200

  • Topics: Stem Cells

Publish with us